Skip to the main content.
Facebook Linkedin X

Press | ​Accelerating Timelines Vital to Securing Slice of Biosimilars Market, KBI

Picture of Admin Admin Sep 3, 2017 5:10:00 AM

News

Accelerating timelines vital to securing slice of biosimilars market, KBI

By Dan Stanton+, 24-Aug-2016

Accelerated development gives biosimilars an upper hand in gaining market share, CMO KBI Biopharma told delegates in Korea yesterday.

http://www.biopharma-reporter.com/Upstream-Processing/Expediting-timelines-key-to-securing-slice-of-biosimilars-market-KBI
KBI Biopharma Named Fill-Finish CDMO of the Year and Best in Class for Cultural Fit in 2026 CDMO Leadership Awards

KBI Biopharma Named Fill-Finish CDMO of the Year and Best in Class for Cultural Fit in 2026 CDMO Leadership Awards

Durham, North Carolina (April 2, 2026) –KBI Biopharma, a leading global contract development and manufacturing organization (CDMO), has been named...

Read More
KBI Biopharma, Inc. Announces Collaboration with Infinimmune Inc. to Support Antibody Manufacturing

KBI Biopharma, Inc. Announces Collaboration with Infinimmune Inc. to Support Antibody Manufacturing

Durham, North Carolina and Alameda, California (September 08, 2025) – KBI Biopharma, Inc. (KBI), a JSR Life Sciences company and cGMP contract...

Read More
KBI Biopharma Awarded as Global Leader in Biologics Manufacturing

KBI Biopharma Awarded as Global Leader in Biologics Manufacturing

Durham, North Carolina (April 3, 2025) – KBI Biopharma, a JSR Life Sciences Company and leading global contract development and manufacturing...

Read More